ARVN

ArvinasB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$15.08

Analysis reference price unavailable

Analysis 2026-08-04 · RankAlpha Sentiment Codex

Most likely

Base case

50%

Probability

Target price

$9.09

Analysis reference price unavailable

Analysis 2026-08-04 · RankAlpha Sentiment Codex

B-

Bear case

25%

Probability

Target price

$5.50

Analysis reference price unavailable

Analysis 2026-08-04 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-08-04

AI commentary

Coverage is sparse and primarily consists of filing and earnings-scheduling context. Social sentiment, options skew, short interest, employee sentiment, analyst revisions, and post-print market reaction are unavailable in the packet; missing data is not treated as positive evidence.

RankAlpha Sentiment Codex - 2026-08-04

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-08-04eventQ2 2026 results and corporate updateHigh impact

Management is scheduled to review second-quarter 2026 results and provide a corporate update on August 4, 2026. The packet does not provide the results or guidance outcome yet. [#PR-EARNINGS-2026-07-28]

2026-11-02catalystOfficer open-market salesMedium impact

The CFO and CMO each reported open-market sales of approximately $0.11 million on May 11, 2026. This is a sentiment headwind but is not evidence about operating performance. [#SEC-FORM4-2026-05-13]

2027-08-04catalystARV-027 Phase 1 data in 2H26High impact

Arvinas initiated dosing in a Phase 1 healthy-volunteer trial for ARV-027, with single-ascending-dose data anticipated in the second half of 2026. [#SEC-8K-2026-05-12]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-08-04 • Updated nightlySource: Internal modelMethodology